Open Access Archives | Page 3 of 4

Oncotarget News

Testimonial: Dr. Michael Roehrl

November 19, 2021

Dr. Michael Roehrl from the Department of Pathology, Memorial Sloan Kettering Cancer Center discusses his experience while publishing the paper, “Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal... read more

Oncotarget

Testimonial: Dr. Reshma Sundar and Dr. Marene Landström

November 12, 2021

Below is a transcript of testimonials by Dr. Reshma Sundar and Dr. Marene Landström from the Department of Medical Biosciences at Umeå University in Sweden on their... read more

Oncotarget

Testimonial: Dr. Michael Andreeff

November 5, 2021

Below is a transcript of the testimonial by Dr. Michael Andreeff, from the University of Texas MD Anderson Cancer Center, about his experience publishing the... read more

Oncotarget

Testimonial: Dr. Ken Pienta

October 29, 2021

Below is the transcript of a testimonial by Dr. Ken Pienta from Johns Hopkins School of Medicine on his experiences publishing numerous research papers with ... read more

Oncotarget

Testimonial: Dr. J. James Frost

October 15, 2021

Below is a transcript of the 2017 testimonial by Dr. J. James Frost, formerly of Johns Hopkins Department of Radiology, about his experience publishing... read more

Oncotarget

Testimonial: Dr. John Hawse

October 8, 2021

Below is a transcript of the testimonial by Dr. John Hawse from the Mayo Clinic in Rochester, MN, about the experience publishing his research paper, "ERβ inhibits cyclin dependent kinases... read more

Oncotarget

Testimonial: Dr. Yves Chabu

September 17, 2021

Below is a transcript of the testimonial by Dr. Yves Chabu about his experience publishing the paper, “Evaluations of CRC2631 toxicity, tumor colonization, and genetic... read more

Oncotarget

Testimonial: Dr. Tapasree Roy Sarkar

September 8, 2021

Below is a transcript of the testimonial by Dr. Tapasree Roy Sarkar from the Department of Biology at Texas A&M University about her... read more

Oncotarget

Captain of Team Open Access Rides Again for Cancer Research

August 16, 2021

For the past four summers, Impact Journals has sponsored Team Open Access in the Ride for Roswell. The peloton has been captained by Sergei Kurenov, who is the... read more

Oncotarget

Why We Ride: Sergei Kurenov

August 5, 2021

Sergei Kurenov is the captain of Team Open Access, and the Director of Surgical Simulation at Roswell Park Comprehensive Cancer Center — one of the leading cancer treatment and research&... read more